TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

176.90$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 204 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
141 156 153 154 155 168 169 182 189 198 194 204 785
105 88 76 85 77 129 78 91 88 104 96 96 384
37 68 77 69 77 39 91 91 101 93 98 108 401
11 10 11 11 9.7 12 13 14 14 12 14 14 55
55 58 61 65 76 61 71 71 74 86 77 77 313
32 68 73 75 85 75 84 77 84 75 80 96 336
4.7 -0.9 3.8 1.5 -7.8 -37 6.6 14 17 19 18 12 65
0.9 8.0 5.5 5.5 5.6 5.5 5.7 5.8 27 5.9 6.0 17 57
11 -8.8 3.7 5.2 -1.1 -39 7.9 18 17 19 1.8 14 52
-5.5 17 0.4 1.9 -0.5 -4.7 2.1 3.3 2.2 5.8 -6.6 9.1 11
17 -25 3.3 3.3 -0.7 -34 5.8 15 15 13 8.3 5.0 42
32 9.5 30 27 21 2.1 36 48 47 45 32 -2.4 122

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?